Neurosurgery & Spine Robots Market

How big is the Neurosurgery & Spine Robots Market in 2026?

USD 881.0 million in 2026 and USD 4,419.0 million by 2036 at a 17.5% CAGR.

Demand for neurosurgery and spine robots is projected to expand at 17.5% CAGR between 2026 and 2036, increasing valuation from USD 881.0 million in 2026 to USD 4,419.0 million by 2036. Robotic assistance improves precision during complex neurosurgery and spine procedures. For example, pedicle screw workflows provide standardized trajectories for these delicate operations. These advanced systems also offer repeatable imaging checkpoints to guide the surgical team. Cranial biopsy and electrode placement further help extend platform use across stereotactic planning. Such diverse features ensure accurate instrument alignment throughout the surgery. High-volume clinical data strongly supports the real-world utility of these platforms. In July 2024, MacLean and colleagues reported reviewing 46 studies covering 25,054 screws. Hospitals expect this evidence to support their comparison of accuracy and revision performance during capital reviews.

Regional priorities heavily influence hospitals by selecting spine and cranial robotic platforms worldwide. Institutions in China weigh domestic service access and compact system availability during their reviews. Hospitals in the United States and Europe stress regulatory documentation and implant compatibility. Specialized cranial workflows provide critical data to guide these distinct purchasing decisions. In February 2024, Kaewborisutsakul and colleagues reported analyzing 11,257 SEEG electrode implantations across 15 studies. This evidence highlights cranial workflow efficiency strengthening specialist-center evaluation with standard spine applications.

Metric	Value
2025 Market Size	USD 749.8 million
2026 Market Size	USD 881.0 million
2036 Market Size	USD 4,419.0 million
Forecast CAGR (2026-2036)	17.5%
Component Focus	Systems
Systems Share (2026)	52.0%
Business Model Focus	Capital Purchase
Capital Purchase Share (2026)	50.0%
Technology Focus	Robotic Guidance Arms
Robotic Guidance Arms Share (2026)	48.0%

Summary of Neurosurgery & Spine Robots Market

Market Signal	Commercial Impact
Demand and Growth Drivers	Neurosurgery and spine robot selection progresses as hospitals connect trajectory accuracy with procedural consistency. Program decisions reflect clinical evidence and specialist training. Spine teams seek repeatable guidance for complex fusion and deformity procedures. Cranial programs evaluate robotic targeting across biopsy and SEEG workflows. Academic centers support multidisciplinary trials and structured surgeon training. Hospitals compare imaging compatibility before adding platforms across surgical departments. Service partners are anticipated to influence installation quality and continuing system readiness.
Product and Segment View	Segment direction is led by systems, followed by capital purchase and robotic guidance arms. Specification review is estimated to center on clinical range and imaging integration. Systems are predicted to represent 52.0% share in 2026 owing to integrated hardware and software value. Capital purchase is anticipated to secure 50.0% share in 2026, reflecting controlled institutional scheduling. Robotic guidance arms are likely to garner 48.0% share in 2026, aided by planned trajectory alignment.
Geography and Growth Outlook	Country movement differs due to regulatory access and specialist-center concentration. Commercial progress reflects local engineering support and clinical training capacity. China is forecast to scale at 20.5% CAGR by 2036, influenced by domestic manufacturing. Japan is projected to rise at 19.5% CAGR during the forecast period, backed by concentrated specialist programs. European Union is estimated to record 18.0% CAGR from 2026 to 2036, guided by established navigation infrastructure.
Competitive View	Competition focuses on clinical range and dependable integration across spine and cranial workflows. Commercial progress favors companies providing regulatory support and responsive technical service. Medtronic plc and Globus Medical, Inc. are expected to compete across integrated spine programs. Zimmer Biomet Holdings, Inc. and Brainlab SE are projected to support cranial and spine workflows. Renishaw plc and Brain Navi Biotechnology Co., Ltd. are anticipated to receive review across stereotactic applications.
Analyst Perspective	Neurosurgery and spine robots are becoming workflow platforms for precision-dependent procedures. Vendor progress is improving based on broader indications and evidence-led hospital evaluation. Managers assess platforms due to accuracy records and procedural compatibility. Surgical teams value systems supporting planned trajectories without restricting implant choice. Local training access improves confidence across multidisciplinary specialist programs. - Anurag Sharma, Principal Consultant for Healthcare at Future Market Insights

Source: Future Market Insights analysis, 2026.

How is neurosurgery & spine robots market segmented?

The neurosurgery & spine robots sector is segmented by application, technology, component, end user, business model, and region.

The neurosurgery & spine robots market is segmented by application and technology and component and end user and business model and region. Application coverage includes pedicle screw placement and stereotactic biopsy within spine and cranial surgical programs. Coverage extends to DBS electrode placement and SEEG and other uses involving planned cranial trajectories. Technology coverage includes robotic guidance arms and navigation-integrated systems serving different operating-room configurations throughout hospital settings. Miniature bone-mounted robots complete technology coverage through compact designs intended for selected complex spine procedures.

Component coverage includes systems and instruments with accessories and services supporting continuing clinical platform use. End users include academic medical centers and neuro specialty hospitals and general hospitals throughout care networks. Business models include capital purchase and per-procedure pricing and lease and placement programs for varied utilization needs. Regional coverage includes USA and EU and China and India and Japan and Rest of World within supplied scope.

Why does pedicle screw placement lead application selection?

Dominguez and colleagues reported in November 2025 recording 99% Grade A placement among 590 evaluated screws, reflecting robotic guidance during thoracolumbar fusion procedures requiring accurate trajectories. Standardized planning helps surgeons align implants for deformity and multilevel cases based on repeatable image-based guidance. Stereotactic biopsy and DBS electrode placement require cranial registration suited to stereotactic surgery devices and specialist clinical teams.

• Pedicle screw placement is set to represent 42.0% share of application in 2026, backed by repeatable trajectories during spinal fusion procedures. Spine teams assess registration stability and implant planning throughout complete procedural stages to preserve placement accuracy.
• Stereotactic biopsy and DBS electrode placement address cranial targeting during tissue sampling and movement-disorder treatment programs. SEEG and other uses support electrode trajectories for epilepsy evaluation and selected functional neurosurgery procedures.

How do robotic guidance arms influence technology demand?

Navigation-integrated systems combine imaging and trajectory feedback within medical robot deployments throughout specialist hospital operating rooms. Lee and colleagues reported in March 2024 identifying 3 current robotic control architectures, clarifying design differences among supervised and remote and shared-control platforms. Robotic guidance arms align instruments to planned trajectories due to tracked movement during complex spinal procedures.

• Robotic guidance arms are anticipated to secure 48.0% share in 2026, led by planned trajectory alignment during pedicle screw procedures. Hospital teams compare arm rigidity and registration stability and imaging compatibility during detailed technology review.
• Navigation-integrated systems consolidate image review and instrument tracking within connected procedural workflows for surgical teams. Miniature bone-mounted robots provide compact assistance for selected spine procedures requiring a limited operating-room footprint.

Why do systems account for component leadership?

Kanhangad and colleagues reported in October 2024 evaluating 1,225 robot-assisted screws, illustrating repeated procedural load handled by complete robotic systems. System value includes arm mechanics and controls and planning interfaces supporting coordinated surgical guidance workflows. Instruments and accessories connect planned trajectories with surgical execution during demanding complex spinal fusion procedures.

• Based on component, systems are forecast to capture 52.0% share in 2026 since complete platforms concentrate robotic hardware and software and tracking controls. Buyers compare clinical range and service readiness and imaging compatibility during detailed institutional system selection.
• Instruments and accessories support drilling and implant delivery throughout assigned procedural workflows within specialist surgery programs. Services support installation and training and maintenance required for dependable equipment availability during scheduled cases.

Why do academic medical centers lead end-user demand?

Brain Navi reported in January 2024 completion of 100 NaoTrac clinical cases at An-Nan National Hospital, demonstrating concentrated case experience within specialist institutions. Academic medical centers combine surgery and training and clinical evaluation depending on multidisciplinary specialist hospital programs. Neuro specialty hospitals extend focused adoption for biopsy and electrode placement and deep brain stimulator programs worldwide.

• In 2026, academic medical centers are projected to hold 46.0% share in 2026 as it is supported by specialist surgeons and clinical research infrastructure and multidisciplinary case review. Evaluation programs compare accuracy and workflow effects during complex spine and cranial procedures under clinical use.
• Neuro specialty hospitals focus on cranial targeting and complex spine care through dedicated clinical teams and specialized equipment. General hospitals require dependable service and clear utilization pathways supporting detailed institutional capital review processes.

How does capital purchase retain business model strength?

Per-procedure pricing and placement programs may extend access to medical automation without full permanent institutional ownership. AIIMS Bhopal listed 1 spine robotic system in July 2024, highlighting institution-led ownership led by formal equipment tendering. Capital purchase supports internal scheduling and asset control throughout several specialist hospital service lines globally.

• By business model, capital purchase is estimated to hold 50.0% share in 2026 owing to hospital control over scheduling and maintenance planning. Institutions connect ownership with trained users and documented equipment readiness for scheduled specialist surgery programs.
• Per-procedure pricing distributes platform cost among completed cases and expected utilization within defined clinical programs. Lease and placement programs offer staged access for hospitals assessing procedural demand and operational readiness.

What are drivers, restraints, and opportunities in neurosurgery & spine robots market?

Accuracy evidence and multi-indication utilization promote neurosurgery and spine robotics evaluation within specialist surgical programs. Capital intensity and workflow complexity may delay general-hospital adoption among institutions with limited procedural volume.

• Driver: Spine teams seek consistent trajectory guidance during complex fusion and deformity procedures involving difficult anatomy. Cranial programs value accurate alignment for biopsy and electrode placement through planned stereotactic guidance workflows.
• Restraint: Registration errors may disrupt planned trajectories during mobile or unstable anatomy within complex procedures. Training demands may delay dependable use among smaller clinical teams lacking extensive prior robotic experience.
• Opportunity: Modular platforms may connect spine and cranial applications through shared imaging infrastructure between hospital departments. Flexible service models are expected to expand access among mid-sized hospitals with selective clinical utilization.

Hospitals are estimated to be the main drivers for the sector by helping to connect clinical accuracy with revision avoidance and radiation management during complex spinal procedures. Guan and colleagues reported in July 2024 robotic assistance produced 74% fewer proximal facet violations during pooled TLIF analysis, highlighting precision-centered platform evaluation.

Technical faults may interrupt planned guidance despite accurate preoperative planning during complex spine surgery procedures. Clinical teams are likely to require registration checks and fallback protocols during every scheduled procedure. Wandvik and colleagues reported in December 2024 identifying 20 screw-related events within an initial 100-case series, reinforcing structured validation requirements.

Cranial indications are projected to extend utilization beyond spine-dominant programs within specialist hospital institutions worldwide. Shared platforms may support DBS and biopsy and SEEG through dedicated software and compatible instruments. Perera and colleagues reported in August 2025 a 1.01 mm robotic radial error during DBS electrode placement, influencing accurate stereotactic expansion.

How are country CAGRs aligned in neurosurgery & spine robots market?

Country	CAGR
China	20.5%
Japan	19.5%
European Union	18.0%
United States	17.0%
India	14.5%

Source: Future Market Insights analysis, 2026.

How do country-level CAGRs compare in neurosurgery & spine robots market?

The country comparison shows a gradual step-down in growth across the markets covered. China and Japan sit at the upper end of the range, followed by the European Union and the United States. India remains at the lower end of the comparison. The six-point spread shows that these markets share a strong growth outlook, although their relative positions indicate different levels of market momentum. European Union figure represents a regional average, so individual member countries may record higher or lower growth.

• China and Japan lead the comparison and establish East Asia as the notable growth cluster among the markets shown.
• European Union and United States follow, although both markets maintain measurable gaps from the leading group.
• India records the slowest growth among the listed markets, yet its forecast remains strong within the wider market context.
• Difference between the leading and middle markets remains moderate compared with India’s lower forecast position.
• Pattern resembles a gradual downward slope rather than a sharp separation between high-growth and low-growth markets.

Markets with broadly similar CAGRs can still present different entry conditions due to specialist-center capacity and regulatory access. The full report provides country-level analysis across North America, Latin America, Europe, East Asia, South Asia, Oceania and the Middle East and Africa.

Country-wise Analysis

• Neurosurgery and spine robots industry in China are anticipated to rise at 20.5% CAGR between 2026 and 2036, backed by domestic manufacturing and expanding specialist capacity. Local servicing helps hospitals evaluate compact and integrated platforms beyond major metropolitan academic centers throughout provincial care networks. National Bureau of Statistics of China reported in January 2025 a population of 220.23 million aged 65 years or older during 2024, increasing potential need for degenerative spine care.
• Concentrated surgical programs permit focused training and rapid diffusion among high-volume specialist institutions throughout Japan. Sales in Japan are projected to expand at 19.5% CAGR through 2036, aided by established robotics experience and structured device review. Statistics Bureau of Japan reported in 2025 an aged population of 36.24 million during 2024, attracting attention toward complex spine care among specialist centers.
• Public hospital systems assess incremental additions connecting robotic alignment with existing imaging equipment among member countries. Eurostat reported in February 2026 an estimated 22.0% of European Union residents aged 65 years or older in 2025, sustaining demand for age-linked spine treatment. The market in European Union is estimated to record 18.0% CAGR from 2026 to 2036, guided by modular navigation infrastructure and cross-border clinical training.
• Sector in the United States is forecast to grow at 17.0% CAGR by 2036, helped by integrated robotics portfolios and specialist training networks. Domestic vendor access supports product evaluation through academic centers and ambulatory programs within numerous states. United States Census Bureau reported in June 2025 a population of 61.2 million aged 65 years or older during 2024, expanding a major patient base for degenerative spine procedures.
• Major institutes provide demonstration sites for trained teams and detailed equipment evaluation throughout government hospital networks. Industry in India is predicted to scale at 14.5% CAGR during forecast period, influenced by selective capital allocation among government and private hospitals. Press Information Bureau projected in October 2025 about 230 million senior citizens by 2036, indicating expanding need for age-related surgical capacity.

Who are notable companies in neurosurgery & spine robots market?

Medtronic plc supports integrated spine and cranial guidance through Mazor and Stealth AXiS platforms within hospital programs. Globus Medical, Inc. adds ExcelsiusGPS navigation for pedicle screw planning during complex spinal procedures. Zimmer Biomet Holdings, Inc. and Brainlab SE serve cranial and spine applications led by robotic alignment and navigation. Renishaw plc and Brain Navi Biotechnology Co., Ltd. focus on stereotactic neurosurgery involving biopsy and electrode placement.

Clinical range and imaging integration and service readiness are likely to drive the competition in neurosurgery and spine robots sector. Medtronic plc is estimated to contribute based on Mazor-based robotics and Stealth AXiS development for clinical applications. Globus Medical, Inc. is expected to compete led by ExcelsiusGPS and connected spine technologies serving complex fusion programs. Zimmer Biomet Holdings, Inc. is projected to support biopsy and DBS and SEEG through ROSA ONE Brain installations.

Brainlab SE is likely to add modular robotic alignment during spine and cranial procedures within navigation-equipped hospitals. Renishaw plc and Brain Navi Biotechnology Co., Ltd. are estimated to serve stereotactic applications through neuromate and NaoTrac systems. eCential Robotics and CUREXO Inc. are anticipated to compete through open and regionally distributed spine platforms for new hospital programs. TINAVI Medical Technologies Co., Ltd. and Sino-European MicroRobotics (Shanghai) Co., Ltd. (SEMR) are projected to support Asian hospital access through domestic engineering and service networks.

• Medtronic plc and Globus Medical, Inc. are expected to receive attention due to integrated spine portfolios and established navigation infrastructure. Hospital teams are likely to assess imaging compatibility and implant workflows during planned fusion procedures.
• Zimmer Biomet Holdings, Inc. and Brainlab SE are anticipated to compete depending on cranial targeting and modular spine alignment. Academic programs are projected to compare application range and registration workflow among specialist clinical teams.
• Renishaw plc and Brain Navi Biotechnology Co., Ltd. are forecast to support DBS and SEEG and biopsy applications. Specialist centers are expected to examine stereotactic accuracy and staff training during planned cranial procedures.
• eCential Robotics and CUREXO Inc. are likely to support open-platform and regional spine programs within hospital networks. Local service access is anticipated to influence installation and continuing equipment readiness during scheduled cases.

Competitive Benchmarking: Neurosurgery & Spine Robots Market

Company	Portfolio Depth	Spine Match	Cranial Match	Service Reach
Medtronic plc	High	High	High	Ireland, United States, and global
Globus Medical, Inc.	High	High	Medium	United States and global
Zimmer Biomet Holdings, Inc.	High	High	High	United States and global
Brainlab SE	High	High	High	Germany and global
Renishaw plc	Medium	Low	High	United Kingdom and global
eCential Robotics	Medium	High	Low	France, United States, and Europe
Brain Navi Biotechnology Co., Ltd.	Medium	Low	High	Taiwan, Asia, Europe, and United States
CUREXO Inc.	Medium	High	Low	South Korea and international markets
TINAVI Medical Technologies Co., Ltd.	Medium	High	Medium	China and selected international markets
Sino-European MicroRobotics (Shanghai) Co., Ltd. (SEMR)	Medium	High	Low	China and Europe

Source: Future Market Insights competitive analysis, 2026.

Key Developments in Neurosurgery & Spine Robots Market

• In March 2025, eCential Robotics received United States FDA 510(k) clearance for Op.n GEN 1. Company reporting linked clearance with simplified third-party implant integration and added modularity for spine applications.
• In June 2025, Brain Navi received United States FDA 510(k) clearance for NaoTrac as a stereotaxic guiding surgical device. Company reporting connected approval with United States access for robotic neurosurgical trajectory guidance within specialist centers.
• In May 2026, CUREXO received Mexican medical-device approval for CUVIS-spine covering robotic spinal surgery applications. Company reporting associated approval with local commercialization and expanded Latin American access for robotic screw guidance.

Key Players in Neurosurgery & Spine Robots Market

Integrated spine and cranial robotics companies

• Medtronic plc
• Globus Medical, Inc.
• Zimmer Biomet Holdings, Inc.
• Brainlab SE

Focused stereotactic and open-platform specialists

• Renishaw plc
• eCential Robotics
• Brain Navi Biotechnology Co., Ltd.

Regional spine robotics manufacturers

• CUREXO Inc.
• TINAVI Medical Technologies Co., Ltd.
• Sino-European MicroRobotics (Shanghai) Co., Ltd. (SEMR)

Neurosurgery & Spine Robots Market Report Scope

Coverage field	Report scope
Market breakdown	Neurosurgery & spine robots market breakdown by application, technology, component, end user, business model, and region
Quantitative Units	USD million in 2026 to USD million by 2036 at a CAGR
Market Definition	Neurosurgery and spine robots include robotic guidance and navigation-integrated platforms supporting spine and cranial procedures within specialist surgical institutions.
Regions Covered	North America, Latin America, Europe, East Asia, South Asia, Oceania, and Middle East and Africa.
Countries Covered	United States, China, European Union, Japan, Russia, Canada, Brazil, Mexico, Germany, France, United Kingdom, Italy, Spain, Poland, India, ASEAN, Australia, New Zealand, GCC countries, South Africa and Türkiye
Key Companies Profiled	Medtronic plc, Globus Medical, Inc., Zimmer Biomet Holdings, Inc., Brainlab SE, Renishaw plc, eCential Robotics, Brain Navi Biotechnology Co., Ltd., CUREXO Inc., TINAVI Medical Technologies Co., Ltd., and Sino-European MicroRobotics (Shanghai) Co., Ltd. (SEMR).
Forecast Period	2026 to 2036
Approach	Hybrid bottom-up and top-down methodology using segment share and country CAGR and procedure mix and product portfolio depth and clinical evidence and service coverage

Source: Future Market Insights analysis, 2026.

Neurosurgery & Spine Robots Market - Research Methodology

Method	Approach
Primary Research	FMI analysts gathered input from manufacturers, service providers, technology developers, distributors, end users, procurement teams, and subject-matter experts. Interviews examined purchasing decisions, product or service evaluation, adoption barriers, approval requirements, pricing considerations, and expectations for technical or commercial support. Respondents were also asked what evidence is required before a trial, pilot, or initial order develops into regular purchasing.
Desk Research	Desk research covered government statistics, regulatory publications, trade data, industry associations, technical literature, standards, company filings, product information, and official corporate announcements. Sources were reviewed for relevance, publication date, geographic coverage, and consistency with the defined market scope. Claims relating to performance, applications, approvals, capacity, investment, and commercial activity were retained only when supported by credible public evidence.
Market Sizing and Forecasting	The market model combined the baseline value with historical performance, segment structure, pricing and volume indicators, adoption levels, company participation, and country-level demand conditions. Forecast assumptions considered economic activity, investment trends, regulatory developments, technology adoption, purchasing cycles, supply availability, and barriers to wider market use. Segment and regional estimates were reconciled before the final market total was calculated.
Data Validation	Estimates were checked against multiple independent indicators, including public data, company activity, trade patterns, industry developments, and findings from primary interviews. Validation also tested whether products, services, applications, and company revenues fell within the defined market boundaries. Adjacent categories, unsupported claims, overlapping revenues, and activities without direct market relevance were excluded to reduce double counting and maintain consistency across segments and countries.

Source: Future Market Insights analysis, 2026.

Neurosurgery & Spine Robots Market by Segments

Neurosurgery & Spine Robots Market segmented by Application:

• Pedicle screw placement
• Stereotactic biopsy
• DBS electrode placement
• SEEG and others

Neurosurgery & Spine Robots Market segmented by Technology:

• Robotic guidance arms
• Navigation-integrated systems
• Miniature bone-mounted robots

Neurosurgery & Spine Robots Market segmented by Component:

• Systems
• Instruments and accessories
• Services

Neurosurgery & Spine Robots Market segmented by End User:

• Academic medical centers
• Neuro specialty hospitals
• General hospitals

Neurosurgery & Spine Robots Market segmented by Business Model:

• Capital purchase
• Per-procedure pricing
• Lease
• Placement programs

Neurosurgery & Spine Robots Market segmented by Region:

• United States
• European Union
• China
• India
• Japan
• Rest of World

Research Sources and Bibliography

• MacLean, L., Hersh, A. M., Bhimreddy, M., Jiang, K., Davidar, A. D., Weber-Levine, C., Alomari, S., Judy, B. F., Lubelski, D., & Theodore, N. (2024). Comparison of accuracy, revision, and perioperative outcomes in robot-assisted spine surgeries: Systematic review and meta-analysis. Journal of Neurosurgery: Spine, 41(4), 519-531.
• Kaewborisutsakul, A., Chernov, M., Yokosako, S., & Kubota, Y. (2024). Usefulness of Robotic Stereotactic Assistance (ROSA®) device for stereoelectroencephalography electrode implantation: A systematic review and meta-analysis. Neurologia Medico-Chirurgica, 64(2), 71-86.
• Dominguez, I., Luque, R., Carrascosa, A., Castaño, J. P., Collado, A., Alonso Lera, P., & Marco, F. (2025). Accuracy of robotic-guided pedicular screw insertion in thoracolumbar spinal surgery. Journal of Clinical Medicine, 14(23), 8425.
• Lee, Y.-S., Cho, D.-C., & Kim, K.-T. (2024). Navigation-guided/robot-assisted spinal surgery: A review article. Neurospine, 21(1), 8-17.
• Kanhangad, M. P., Srinivasa, V., Thirugnanam, B., Soni, A., Kashyap, A., Vidyadhara, A., & Rao, S. K. (2024). Robotic spine systems: Overcoming surgeon experience in pedicle screw accuracy: A prospective study. Asian Spine Journal, 18(5), 663-672.
• Brain Navi Biotechnology Co., Ltd. (2024, January 17). Brain Navi announces 100th surgical procedure completed using NaoTrac.
• All India Institute of Medical Sciences Bhopal. (2024, July 31). Robotic system spine machine for Department of Orthopedics.
• Guan, J., Feng, N., Yu, X., & Yang, K. (2024). Comparison of robot-assisted versus fluoroscopy-guided transforaminal lumbar interbody fusion for lumbar degenerative diseases: A systematic review and meta-analysis of randomized controlled trails and cohort studies. Systematic Reviews, 13, 170.
• Wandvik, C., Greil, M. E., Colby, S., Gautam, D., & Mazur, M. D. (2024). Limitations of current robot-assisted pedicle screw insertion systems. Neurosurgical Focus, 57(6), E14.
• Perera, D., Roldán Ramos, P., Valldeoriola, F., Sánchez-Gómez, A., Ferrés, A., Pérez-Baldioceda, C., Cabrera, G., Mosteiro, A., Gómez, L., Codes, M., Manfrellotti, R., & Rumià, J. (2025). Robotic arm vs. stereotactic frame in deep brain stimulation surgery for movement disorders: A retrospective cohort study. Acta Neurochirurgica, 167, 219.
• National Bureau of Statistics of China. (2025, January 17). National economy witnessed steady progress amidst stability with major development targets achieved successfully in 2024.
• Statistics Bureau of Japan. (2025). Statistical handbook of Japan 2025.
• Eurostat. (2026, February 2). Population structure and ageing.
• United States Census Bureau. (2025, June 26). Older adults outnumber children in 11 states and nearly half of United States counties.
• Press Information Bureau. (2025, October 28). India’s silver dividend: Empowering senior citizens for a brighter future.
• eCential Robotics. (2025, March 14). eCential Robotics receives FDA 510(k) clearance for its next generation of open navigation and robotic platform for spine: Op.n GEN 1.
• Brain Navi Biotechnology Co., Ltd. (2025, June 19). Brain Navi achieves United States FDA approval for neurosurgical robot NaoTrac.
• CUREXO Inc. (2026, May 27). CUVIS-spine surgical robot receives medical device approval in Mexico.

This bibliography is provided for reader reference and is not exhaustive. The full report contains the complete reference list and detailed citations.

This Report Answers

• What segments influence demand across application and technology and component and end user and business model?
• How do hospitals evaluate neurosurgery and spine robots prior to replacing manual guidance routines across specialist procedures?
• How do country CAGRs differ across profiled markets with distinct regulatory and hospital investment conditions?
• What companies compete through spine and cranial portfolio depth and dependable service support across hospital programs?
• How are forecasts validated through a hybrid bottom-up and top-down approach across defined market segments?
• What factors do hospital teams examine prior to program expansion across spine and cranial service lines?
• How do application range and imaging compatibility affect platform selection across specialist surgical institutions?
• What limits return on investment for institutions adding neurosurgery and spine robots across several procedure types?
• How do clinical records and training guidance influence account approval across multidisciplinary hospital review teams?
• What vendor capabilities improve long-term hospital confidence across installation and training and continuing service support?